Beaupre Darrin 4
4 · IDEAYA Biosciences, Inc. · Filed Feb 28, 2025
Insider Transaction Report
Form 4
Beaupre Darrin
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-27+185,000→ 185,000 totalExercise: $20.24Exp: 2035-02-26→ Common Stock (185,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.